中华放射肿瘤学杂志
中華放射腫瘤學雜誌
중화방사종류학잡지
CHINESE JOURNAL OF RADIATION ONCOLOGY
2015年
5期
569-572
,共4页
于浪%张宇%孙显松%王欣海%晏俊芳%杨波%邱杰
于浪%張宇%孫顯鬆%王訢海%晏俊芳%楊波%邱傑
우랑%장우%손현송%왕흔해%안준방%양파%구걸
子宫内膜癌/三维腔内近距离疗法%剂量体积直方图%体重指数
子宮內膜癌/三維腔內近距離療法%劑量體積直方圖%體重指數
자궁내막암/삼유강내근거리요법%제량체적직방도%체중지수
Endometrial carcinoma/three-dimensional intracavitary brachytherapy%Dose volume histogram%Body mass index
目的:通过比较子宫内膜癌腔内近距离治疗3D计划和2D计划,探讨子宫内膜癌3D腔内近距离治疗的剂量学特性。方法回顾性分析11例子宫内膜癌患者的39次3D近距离治疗计划并重新设计2D计划,从DVH上比较靶区V150、D90,膀胱、直肠、小肠及乙状结肠D2 cm3。采用配对t检验方法分析组间差异。结果靶体积<60 cm3时,3D、2D计划靶区D90分别为(551?17±90?33)、(574?15±117?18) cGy (P=0?390),随着靶体积增加3D计划的D90增加(P=0?001)。3D、2D计划靶区V150分别为(51?05±21?61)、(53?41±11?71) cm3(P=0?482)。当靶体积>60 cm3时,与2D计划相比,3D计划提高靶区覆盖同时增加了危及器官受量,但小肠受量增加不明显( P=0?128)。此外,不同计划模式下BMI增加对直肠、小肠、膀胱及乙状结肠的受量无显著影响, P值分别为0?239、0?198、0?744和0?834。结论子宫内膜癌3D腔内近距离治疗与2D计划相比可显著提高较大靶区的覆盖范围,有效控制OAR受量,临床疗效与不良反应尚需进一步观察。
目的:通過比較子宮內膜癌腔內近距離治療3D計劃和2D計劃,探討子宮內膜癌3D腔內近距離治療的劑量學特性。方法迴顧性分析11例子宮內膜癌患者的39次3D近距離治療計劃併重新設計2D計劃,從DVH上比較靶區V150、D90,膀胱、直腸、小腸及乙狀結腸D2 cm3。採用配對t檢驗方法分析組間差異。結果靶體積<60 cm3時,3D、2D計劃靶區D90分彆為(551?17±90?33)、(574?15±117?18) cGy (P=0?390),隨著靶體積增加3D計劃的D90增加(P=0?001)。3D、2D計劃靶區V150分彆為(51?05±21?61)、(53?41±11?71) cm3(P=0?482)。噹靶體積>60 cm3時,與2D計劃相比,3D計劃提高靶區覆蓋同時增加瞭危及器官受量,但小腸受量增加不明顯( P=0?128)。此外,不同計劃模式下BMI增加對直腸、小腸、膀胱及乙狀結腸的受量無顯著影響, P值分彆為0?239、0?198、0?744和0?834。結論子宮內膜癌3D腔內近距離治療與2D計劃相比可顯著提高較大靶區的覆蓋範圍,有效控製OAR受量,臨床療效與不良反應尚需進一步觀察。
목적:통과비교자궁내막암강내근거리치료3D계화화2D계화,탐토자궁내막암3D강내근거리치료적제량학특성。방법회고성분석11례자궁내막암환자적39차3D근거리치료계화병중신설계2D계화,종DVH상비교파구V150、D90,방광、직장、소장급을상결장D2 cm3。채용배대t검험방법분석조간차이。결과파체적<60 cm3시,3D、2D계화파구D90분별위(551?17±90?33)、(574?15±117?18) cGy (P=0?390),수착파체적증가3D계화적D90증가(P=0?001)。3D、2D계화파구V150분별위(51?05±21?61)、(53?41±11?71) cm3(P=0?482)。당파체적>60 cm3시,여2D계화상비,3D계화제고파구복개동시증가료위급기관수량,단소장수량증가불명현( P=0?128)。차외,불동계화모식하BMI증가대직장、소장、방광급을상결장적수량무현저영향, P치분별위0?239、0?198、0?744화0?834。결론자궁내막암3D강내근거리치료여2D계화상비가현저제고교대파구적복개범위,유효공제OAR수량,림상료효여불량반응상수진일보관찰。
Objective To study the dosimetric peculiarity of 3D intracavitary brachytherapy in the application of endometrial carcinoma comparing with traditional 2D plans. Method 39 3D brachytherapy treatment plans of 11 patients with endometrial carcinoma were retrospectively analyzed with re?planning 2D treatment plan, the dose volume histogram ( DVH) parameters such as the target dose volume parameters V150 and D90 , the 2?cc doses to organs such as bladder, small intestine, rectum and sigmoid and the total reference air kerma TRAK were analyzed. The differences between the two groups are compared by paired samples T test. Results For target with V<60 cm3 ,there is no statistically significant difference between 2D and 3D plans,the D90 is (551?17±90?33) cGy and (574?15±117?18) cGy,respectively (P=0?390). As the increase of target volume,the D90 came to be significantly different ( P=0?001) , high dose region V150 for 3D and 2D plans is (51?05±21?61) cm3 and (53?41±11?71) cm3, respectively (P=0?482). With the target volume larger than 60 cm3 ,compare to 2D plans, the 3D plan can increase the target coverage as well as OAR dose except for small intestine ( P=0?128) . In addition, with different plan mode,the BMI did not affect the crisis organ dose such as rectum, small intestine, bladder and sigmoid, the P value is 0?239, 0?198,0?744 and 0?834,respectively. Conclusions For endometrial carcinoma,compared with traditional two?dimensional plans,the 3D brachytherapy treatment plans can significantly improve the target coverage and avoiding overdose of organs, clinical curative effect and side effect still needs further observation.